Join
Live feed
·
INSIDERFilingvia Quantisnow
Avanos Medical Inc. logo

Interim CEO Greiner Michael was granted 44,189 shares, increasing direct ownership by 30% to 190,898 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVNS (Avanos Medical Inc.) and more on Quantisnow.